Liquid Biopsy for Colorectal Cancer Appears Promising But Still Lacks Robust Efficacy
March 27, 2024
Responding to a new study suggesting blood-based liquid biopsy tests would result in worse outcomes at an increased cost, David Lieberman, M.D., co-authors a commentary in Clinical Gastroenterology and Hepatology, noting, "Because liquid biopsy is predicted to be less effective and more costly than currently established screening programs, it cannot be recommended to replace established effective screening methods."